U.S. Biotechnology Market Size, Share & Trends Analysis Report By Technology (Nanobiotechnology, Tissue Engineering and Regeneration), By Application (Health, Food & Agriculture), And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                      1.1. Market Segmentation & Scope
                      1.2. Segment Definitions
                          1.2.1. Technology
                          1.2.2. Application
                          1.2.3. Estimates and forecasts timeline
                      1.3. Research Methodology
                      1.4. Information Procurement
                          1.4.1. Purchased database
                          1.4.2. GVR’s internal database
                          1.4.3. Secondary sources
                          1.4.4. Primary research
                          1.4.5. Details of primary research
                              1.4.5.1. Data for primary interviews in U.S.
                      1.5. Information or Data Analysis
                          1.5.1. Data analysis models
                      1.6. Market Formulation & Validation
                      1.7. Model Details
                          1.7.1. Commodity flow analysis (Model 1)
                          1.7.2. Approach 1: Commodity flow approach
                      1.8. List of Secondary Sources
                      1.9. List of Primary Sources
                      1.10. Objectives
Chapter 2. Executive Summary
                      2.1. Market Outlook
                      2.2. Segment Outlook
                          2.2.1. Technology Outlook
                          2.2.2. Application Outlook
                      2.3. Competitive Insights
Chapter 3. U.S. Biotechnology Market Variables, Trends & Scope
                      3.1. Market Lineage Outlook
                          3.1.1. Parent market outlook
                          3.1.2. Related/ancillary market outlook
                      3.2. Market Dynamics
                          3.2.1. Market driver analysis
                              3.2.1.1. Advantages associated with the implementation of single-use technology in biomanufacturing process
                              3.2.1.2. Rising demand for agro-based products
                              3.2.1.3. Growing demand for synthetic biology
                              3.2.1.4. Declining prices of DNA sequencing
                              3.2.1.5. Growing healthcare expenditure boosting development of effective personalized diagnostic & therapeutic procedures for cancer
                          3.2.2. Market restraint analysis
                              3.2.2.1. Ethical & legal limitations
                              3.2.2.2. Risks associated with GM organisms and crops
                              3.2.2.3. Challenges associated with NGS implementation
                      3.3. U.S. Biotechnology Market Analysis Tools
                          3.3.1. Industry Analysis - Porter’s Five Forces
                              3.3.1.1. Threat of new entrant
                              3.3.1.2. Threat of substitues
                              3.3.1.3. Bargaining power of buyers
                              3.3.1.4. Bargaining power of suppliers
                              3.3.1.5. Competitive rivalry
                          3.3.2. PESTEL Analysis
                              3.3.2.1. Political & legal landscape
                              3.3.2.2. Economic landscape
                              3.3.2.3. Social landscape
                              3.3.2.4. Technological landscape
                              3.3.2.5. Environmental landscape
Chapter 4. U.S. Biotechnology Market: Technology Estimates & Trend Analysis
                      4.1. U.S. Biotechnology Market: Technology Dashboard
                      4.2. U.S. Biotechnology Market: Technology Movement Analysis
                      4.3. U.S. Biotechnology Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                      4.4. Nanobiotechnology
                          4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.5. Tissue Engineering and Regeneration
                          4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.6. DN Sequencing
                          4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.7. Cell-based Assays
                          4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.8. Fermentation
                          4.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.9. PCR Technology
                          4.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.10. Chromatography
                          4.10.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      4.11. Others
                          4.11.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Biotechnology Market: Application Estimates & Trend Analysis
                      5.1. U.S. Biotechnology Market: Application Dashboard
                      5.2. U.S. Biotechnology Market: Application Movement Analysis
                      5.3. U.S. Biotechnology Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                      5.4. Health
                          5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      5.5. Food & Agriculture
                          5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      5.6. Natural Resources & Environment
                          5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      5.7. Industrial Processing
                          5.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      5.8. Bioinformatics
                          5.8.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
                      5.9. Others
                          5.9.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. Competitive Landscape
                      6.1. Recent Developments & Impact Analysis, By Key Market Participants
                      6.2. Company/Competition Categorization
                      6.3. Vendor Landscape
                          6.3.1. List of key distributors and channel partners
                          6.3.2. Key customers
                          6.3.3. Key company market share analysis, 2023
                          6.3.4. AstraZeneca
                              6.3.4.1. Company overview
                              6.3.4.2. Financial performance
                              6.3.4.3. Product benchmarking
                              6.3.4.4. Strategic initiatives
                          6.3.5. Gilead Sciences, Inc.
                              6.3.5.1. Company overview
                              6.3.5.2. Financial performance
                              6.3.5.3. Product benchmarking
                              6.3.5.4. Strategic initiatives
                          6.3.6. Bristol-Myers Squibb
                              6.3.6.1. Company overview
                              6.3.6.2. Financial performance
                              6.3.6.3. Product benchmarking
                              6.3.6.4. Strategic initiatives
                          6.3.7. Sanofi
                              6.3.7.1. Company overview
                              6.3.7.2. Financial performance
                              6.3.7.3. Product benchmarking
                              6.3.7.4. Strategic initiatives
                          6.3.8. Biogen
                              6.3.8.1. Company overview
                              6.3.8.2. Financial performance
                              6.3.8.3. Product benchmarking
                              6.3.8.4. Strategic initiatives
                          6.3.9. Abbott Laboratories
                              6.3.9.1. Company overview
                              6.3.9.2. Financial performance
                              6.3.9.3. Product benchmarking
                              6.3.9.4. Strategic initiatives
                          6.3.10. Pfizer, Inc.
                              6.3.10.1. Company overview
                              6.3.10.2. Financial performance
                              6.3.10.3. Product benchmarking
                              6.3.10.4. Strategic initiatives
                          6.3.11. Amgen Inc.
                              6.3.11.1. Company overview
                              6.3.11.2. Financial performance
                              6.3.11.3. Product benchmarking
                              6.3.11.4. Strategic initiatives
                          6.3.12. Novo Nordisk A/S
                              6.3.12.1. Company overview
                              6.3.12.2. Financial performance
                              6.3.12.3. Product benchmarking
                              6.3.12.4. Strategic initiatives
                          6.3.13. Merck KGaA
                              6.3.13.1. Company overview
                              6.3.13.2. Financial performance
                              6.3.13.3. Product benchmarking
                              6.3.13.4. Strategic initiatives
                          6.3.14. Johnson & Johnson Services, Inc.
                              6.3.14.1. Company overview
                              6.3.14.2. Financial performance
                              6.3.14.3. Product benchmarking
                              6.3.14.4. Strategic initiatives
                          6.3.15. Novartis AG
                              6.3.15.1. Company overview
                              6.3.15.2. Financial performance
                              6.3.15.3. Product benchmarking
                              6.3.15.4. Strategic initiatives
                         6.3.16. F. Hoffmann-La Roche Ltd.
                              6.3.16.1. Company overview
                              6.3.16.2. Financial performance
                              6.3.16.3. Product benchmarking
                              6.3.16.4. Strategic initiatives
                          6.3.17. Lonza
                              6.3.17.1. Company overview
                              6.3.17.2. Financial performance
                              6.3.17.3. Product benchmarking
                              6.3.17.4. Strategic initiatives

List of Tables

Table 1. List of abbreviations
Table 2. U.S. Biotechnology Market, by Technology, 2018 - 2030 (USD Billion) 
Table 3. U.S. Biotechnology Market, by Application, 2018 - 2030 (USD Billion) 

List of Figures

Fig. 1 U.S. biotechnology market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 End-use and end-use segment snapshot
Fig. 10 Sales channel and age segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Market dynamics
Fig. 13 Porter’s Five Forces analysis
Fig. 14 PESTLE analysis
Fig. 15 U.S. biotechnology market: Technology outlook and key takeaways
Fig. 16 U.S. biotechnology market: Technology movement analysis
Fig. 17 Nanobiotechnology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 18 Tissue engineering and regeneration market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 19 DNA sequencing market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Cell-based assays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Fermentation market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 PCR technology market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Chromatography market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 U.S. biotechnology market: Application outlook and key takeaways
Fig. 26 U.S. biotechnology market: Application movement analysis
Fig. 27 Health market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 28 Food & agriculture market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Natural resources & environment market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 Industrial processing market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 31 Bioinformatics market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 33 Company market share analysis, 2023
Fig. 34 Strategic framework